Skip to main content

Cipher Pharmaceuticals Inc (CPH-T) Quote

Unchecking box will stop auto data updates
TSX Real-Time Last Sale CAD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 1.33
Day High 1.42
Open:1.42
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Top 1000
Cipher Pharmaceuticals is ranked 578 out of The Top 1000, Report on Business magazine’s exclusive ranking of Canada’s largest companies.
Description
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company, focused on Dermatology. The firm and its subsidiaries develop and acquire products that fulfill unmet medical needs and manage the required clinical development and regulatory process. The company also markets those products directly in Canada and United States or indirectly through partners in the United States, Canada, and South America. The firm mainly operates in Canada and United States and derives the majority of its revenues from Canada.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

ValuEngine Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Cipher Pharmaceuticals Reports Second Quarter 2019 Financial Results
- PR Newswire - Fri Aug 9, 6:00AM CDT
PR Newswire - PRNW
Fri Aug 9, 6:00AM CDT
Cipher Pharmaceuticals Reports Second Quarter 2019 Financial Results
- CNW Group - Fri Aug 9, 6:00AM CDT
CNW Group - CMTX
Fri Aug 9, 6:00AM CDT
Company also provides update on strategic priorities
Notice of Cipher Pharmaceuticals Q2 2019 Conference Call
PR Newswire - Tue Jul 30, 6:30AM CDT
PR Newswire - PRNW
Tue Jul 30, 6:30AM CDT
OAKVILLE, ON , July 30, 2019 /CNW/ -   Cipher Pharmaceuticals Inc. (TSX:CPH) ("Cipher" or "the Company") today announced the details of its Q2 2019 financial results conference call on Friday, August 9, 2019 .
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 1.18 +16.10% increase
on 08/19/19
Period Open:1.35
Price movement based on the high, low and last over the given period.
1.50 -8.67% decrease
on 09/13/19
+0.02 (+1.48%) increase
since 08/16/19
3-Month 1.12 +22.32% increase
on 08/15/19
Period Open:1.21
Price movement based on the high, low and last over the given period.
1.50 -8.67% decrease
on 09/13/19
+0.16 (+13.22%) increase
since 06/18/19
52-Week 1.11 +23.42% increase
on 05/29/19
Period Open:3.09
Price movement based on the high, low and last over the given period.
3.44 -60.17% decrease
on 10/01/18
-1.72 (-55.66%) decrease
since 09/18/18

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2019.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).